Levonorgestrel and mifepristone in emergency contraceptionVON HERTZEN, Helena; PIAGGIO, Gilda.Steroids. 2003, Vol 68, Num 10-13, pp 1107-1113, issn 0039-128X, 7 p.Conference Paper

Bilan d'une année d'utilisation de la mifépristone pour les interruptions de grossesse = First experiences with mifepristone in pregnancy interruptionsSCHNEIDER, N; VIARDOT, C; WIRTHNER, D et al.Médecine et hygiène. 2001, Vol 59, Num 2362, pp 1872-1877, issn 0025-6749, 4 p.Article

L'IVG médicamenteuse fait école en villeMIGNOT, Sandra.L'INFIRMIERE MAGAZINE. 2008, Num 240, pp 42-43, issn 0981-0560, 2 p.Article

The use of mifepristone in the treatment of neuropsychiatric disordersDEBATTISTA, Charles; BELANOFF, Joseph.Trends in endocrinology and metabolism. 2006, Vol 17, Num 3, pp 117-121, issn 1043-2760, 5 p.Article

Mifepristone and prostaglandin for termination of pregnancy : contraindications for use, reasons and rationaleDAVEY, Angela.Contraception (Stoneham). 2006, Vol 74, Num 1, pp 16-20, issn 0010-7824, 5 p.Article

Mifépristone à la dose de 100 mg dans les avortements médicamenteux = Mifepristone 100mg for early medical abortionJERBI, M; HIDAR, S; SAHRAOUI, W et al.Journal de gynécologie obstétrique et biologie de la reproduction. 2005, Vol 34, Num 3, pp 257-261, issn 0368-2315, 5 p., CAH1Article

Can mifepristone medication abortion be successfully integrated into medical practices that do not offer surgical abortion?LEEMAN, Lawrence; ASARIA, Sheemain; ESPEY, Eve et al.Contraception (Stoneham). 2007, Vol 76, Num 2, pp 96-100, issn 0010-7824, 5 p.Article

Low-dose mifepristone increases uterine expression of aquaporin 1/aquaporin 2 at the time of implantationFENG ZHOU; YUN LIANG; QIAN, Zhi-Da et al.Contraception (Stoneham). 2013, Vol 87, Num 6, pp 844-849, issn 0010-7824, 6 p.Article

Acceptability of home use of mifepristone for medical abortionSWICA, Yael; CHONG, Erica; MIDDLETON, Tamer et al.Contraception (Stoneham). 2013, Vol 88, Num 1, pp 122-127, issn 0010-7824, 6 p.Article

Safety of mifepristone abortions in clinical useHENDERSON, Jillian T; HWANG, Ann C; HARPER, Cynthia C et al.Contraception (Stoneham). 2005, Vol 72, Num 3, pp 175-178, issn 0010-7824, 4 p.Article

Effects of RU 486 on hippocampal slice electrophysiology in normal and adrenalectomized BALB/c miceREY, M; CARLIER, E; SOUMIREU-MOURAT, B et al.Neuroendocrinology (Basel). 1989, Vol 49, Num 2, pp 120-124, issn 0028-3835, 5 p.Article

Mifepristone teratogenicityPONS, J.-C; PAPIERNIK, E.Lancet (British edition). 1991, Vol 338, Num 8778, pp 1332-1333, issn 0140-6736Article

Development after exposure to mifepristone in early pregnancyPONS, J.-C; IMBERT, M.-C; ELEFANT, E et al.Lancet (British edition). 1991, Vol 338, Num 8769, issn 0140-6736, p. 763Article

Transvaginal ultrasound and the success of medical abortionEDELMAN, A; THOMAS, L; JENSEN, J et al.International journal of gynaecology and obstetrics. 2004, Vol 85, Num 1, pp 62-63, issn 0020-7292, 2 p.Article

Les antiprogestérones = AntiprogestinsSITRUK-WARE, R.La Presse médicale (1983). 1999, Vol 28, Num 38, pp 2123-2131, issn 0755-4982Article

Dispute surfaces over paternity of RU 486CHERFAS, J.Science (Washington, D.C.). 1989, Vol 246, issn 0036-8075, 994Article

RU 486 - Pro und Contra = RU 486- For and againstREITER-THEIL, S.Ethik in der Medizin. 1992, Vol 4, Num 2, pp 59-61, issn 0935-7335Article

A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trialBRACKEN, Hillary; DABASH, Rasha; PLATAIS, Ingrida et al.Contraception (Stoneham). 2014, Vol 89, Num 3, pp 181-186, issn 0010-7824, 6 p.Article

Impaired imprinting and social behaviors in chicks exposed to mifepristone, a glucocorticoid receptor antagonist, during the final week of embryogenesisNISHIGORI, Hideo; KAGAMI, Keisuke; NISHIGORI, Hidekazu et al.Behavioural brain research. 2014, Vol 261, pp 134-139, issn 0166-4328, 6 p.Article

First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic reviewRAYMOND, Elizabeth G; SHANNON, Caitlin; WEAVER, Mark A et al.Contraception (Stoneham). 2013, Vol 87, Num 1, pp 26-37, issn 0010-7824, 12 p.Article

Sonographic patterns of the endometrium in assessment of medical abortion outcomesTZENG, Chii-Ruey; HWANG, Jiann-Loung; AU, Heng-Kien et al.Contraception (Stoneham). 2013, Vol 88, Num 1, pp 153-159, issn 0010-7824, 7 p.Article

Mifepristone increases gamma-retroviral infection efficiency by enhancing the integration of virus into the genome of infected cellsSOLODUSHKO, V; FOUTY, B.Gene therapy (Basingstoke). 2010, Vol 17, Num 10, pp 1253-1261, issn 0969-7128, 9 p.Article

Mifepristone-induced abortion and placental complications in subsequent pregnancyZHU, Qian-Xi; GAO, Er-Sheng; CHEN, Ai-Min et al.Human reproduction (Oxford. Print). 2009, Vol 24, Num 2, pp 315-319, issn 0268-1161, 5 p.Article

Quantitative analysis of RU38486 (mifepristone) by HPLC triple quadrupole mass spectrometryHOMER, Natalie Z. M; REYNOLDS, Rebecca M; MATTSSON, Cecilia et al.Journal of chromatography. B. 2009, Vol 877, Num 5-6, pp 497-501, issn 1570-0232, 5 p.Article

Vaginal misoprostol for salvage therapy after failed medical abortionLI, Yiu-Tai; CHEN, Tien-Hui; KUO, Tsung-Cheng et al.International journal of gynaecology and obstetrics. 2007, Vol 96, Num 1, pp 52-53, issn 0020-7292, 2 p.Article